Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by wrongturnon Nov 06, 2007 3:50pm
247 Views
Post# 13762365

RE: MD&A question/tcdrugs

RE: MD&A question/tcdrugsDouble edged sword dealing with large pharmas. You need them to take your small company to the next level but they can control you in the process. I've been reading your posts tcdrugs and I also think you might be correct. Is there also a patent issue if the psoriasis drug comes out first? Ie, it is the same molecule so does the patent clock start ticking when the first drug is approved? Also, would it not have made sense to slightly alter the molecule for the other indication? (I read something about this years back.) It would have kept things easier to manage. I'm not sure if Isotechnika management knows what the future holds themselves. Roche keeps Isotechnika unsure therefore the company can't give much information to shareholders. It's interesting how Isotechnika's financing takes them just about to when Roche has to make their decision.
Bullboard Posts